A Study of Bosmolisib (BR101801) in Participants With R/R PTCL.

Starting soon · Phase 2

Conditions studied: Peripheral T Cell Lymphoma

In brief

The objective of this phase II study is to evaluate the efficacy and safety of BR101801 in patients with peripheral T-cell lymphoma(PTCL).

Key facts

Study ID

NCT07180771

Run by

Boryung Pharmaceutical Co., Ltd

People needed

44

Starts

2026-02-01

Expected to finish

2027-09-01

Last updated by the study team

2026-01-28

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.